Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Rapid Micro Biosystems Inc (NASDAQ: RPID) closed the day trading at $3.04 down -0.98% from the previous closing price of $3.07. In other words, the price has decreased by -$0.98 from its previous closing price. On the day, 0.87 million shares were traded. RPID stock price reached its highest trading level at $3.11 during the session, while it also had its lowest trading level at $2.92.
Ratios:
For a better understanding of RPID, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.95 and its Current Ratio is at 4.23. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.52.
Upgrades & Downgrades
In the most recent recommendation for this company, Lake Street on July 28, 2025, initiated with a Buy rating and assigned the stock a target price of $8.
On February 12, 2025, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 11 ’25 when Spignesi Robert G. Jr. sold 11,874 shares for $3.33 per share. The transaction valued at 39,499 led to the insider holds 957,286 shares of the business.
Spignesi Robert G. Jr. sold 11,881 shares of RPID for $39,481 on Jul 14 ’25. The PRESIDENT AND CEO now owns 970,550 shares after completing the transaction at $3.32 per share. On Jul 14 ’25, another insider, Spignesi Robert G. Jr., who serves as the Officer of the company, bought 11,881 shares for $3.32 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RPID now has a Market Capitalization of 134740576 and an Enterprise Value of 98072568. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.41 while its Price-to-Book (P/B) ratio in mrq is 3.04. Its current Enterprise Value per Revenue stands at 3.213 whereas that against EBITDA is -2.309.
Stock Price History:
The Beta on a monthly basis for RPID is 1.38, which has changed by 1.4268775 over the last 52 weeks, in comparison to a change of 0.1726681 over the same period for the S&P500. Over the past 52 weeks, RPID has reached a high of $4.50, while it has fallen to a 52-week low of $1.02. The 50-Day Moving Average of the stock is -14.18%, while the 200-Day Moving Average is calculated to be -4.33%.
Shares Statistics:
Over the past 3-months, RPID traded about 130.57K shares per day on average, while over the past 10 days, RPID traded about 230400 shares per day. A total of 39.81M shares are outstanding, with a floating share count of 23.65M. Insiders hold about 46.65% of the company’s shares, while institutions hold 20.10% stake in the company. Shares short for RPID as of 1767139200 were 178907 with a Short Ratio of 1.37, compared to 1764288000 on 238781. Therefore, it implies a Short% of Shares Outstanding of 178907 and a Short% of Float of 1.39.
Earnings Estimates
. The current assessment of Rapid Micro Biosystems Inc (RPID) involves the perspectives of 3.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$1.0 and -$1.02 for the fiscal current year, implying an average EPS of -$1.01. EPS for the following year is -$0.86, with 4.0 analysts recommending between -$0.81 and -$0.91.
Revenue Estimates
4 analysts predict $11.2M in revenue. The current quarter. It ranges from a high estimate of $12.6M to a low estimate of $10.7M. As of. The current estimate, Rapid Micro Biosystems Inc’s year-ago sales were $8.22MFor the next quarter, 4 analysts are estimating revenue of $8.9M. There is a high estimate of $8.9M for the next quarter, whereas the lowest estimate is $8.9M.
A total of 4 analysts have provided revenue estimates for RPID’s current fiscal year. The highest revenue estimate was $34.9M, while the lowest revenue estimate was $33M, resulting in an average revenue estimate of $33.5M. In the same quarter a year ago, actual revenue was $28.05MBased on 4 analysts’ estimates, the company’s revenue will be $39.65M in the next fiscal year. The high estimate is $40M and the low estimate is $39.3M.
